U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07231588) titled 'Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation' on Nov. 12.
Brief Summary: This research is to determine if an oral probiotic, Pendulum Glucose Control (PGC), can be safely given to patients during pelvic radiation therapy (RT). The researchers will study if the probiotics lessen gastrointestinal toxicity during pelvic radiation.
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Radiation Injuries
Intervention:
BIOLOGICAL: Pendulum Glucose Control (PGC)
Pendulum Glucose Control (PGC) WBF-038 - 2 capsules Orally with food. Once daily for 10 weeks
Recruitment Status: NOT_YET_RECRUITING...